Marlous Kooijman

Utrecht University — Netherlands

Computer Science · Physical Sciences

7h-index474citations7works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Computational Drug Discovery Methods(3), Biosimilars and Bioanalytical Methods(3), Monoclonal and Polyclonal Antibodies Research(2), Innovation and Knowledge Management(1), T-cell and B-cell Immunology(1)

Publications7 total

How institutional logics hamper innovation: The case of animal testing
Technological Forecasting and Social Change·2017· 28 citedOpen Access
Contribution of animal studies to evaluate the similarity of biosimilars to reference products
Drug Discovery Today·2014· 25 citedOpen Access
Why Animal Studies are Still Being Used in Drug Development
Alternatives to Laboratory Animals·2013· 13 cited
Immunogenicity of mAbs in non-human primates during nonclinical safety assessment
mAbs·2013· 128 citedOpen Access
The ability of animal studies to detect serious post marketing adverse events is limited
Regulatory Toxicology and Pharmacology·2012· 60 citedOpen Access
Thirty years of preclinical safety evaluation of biopharmaceuticals: did scientific progress lead to appropriate regulatory guidance?
Expert Opinion on Drug Safety·2012· 21 citedOpen Access
Nonnatural Amino Acids for Site-Specific Protein Conjugation
Bioconjugate Chemistry·2009· 199 cited

Frequent Co-authors

Peter J.K. van Meer(5), Ellen H.M. Moors(5), Huub Schellekens(5), Christine C. Gispen‐de Wied(3), Beatriz Silva Lima(2), Albert J. de Graaf(1), Wim E. Hennink(1), Enrico Mastrobattista(1), Vera Brinks(1), Marko P. Hekkert(1), Hans C. Ebbers(1)